Sign in and upgrade to a paid plan to export corporate actions as CSV.

KOBO BIOTECH LIMITED

Chemicals · Chemicals & Petrochemicals

BSE: 531541
₹3.69
▼ -0.07 (-1.86%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
—/100
Weak
Valuation
—/100
Data unavailable
Momentum
25/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹9 Cr
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-10.4
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
-4.00%
as of Dec. 31, 2023
Industry median 39.08% (220 companies)
Net Profit Growth (TTM)
-0.94%
as of June 30, 2024
Industry median 13.45% (212 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2024
Industry median 7.93% (209 companies)
Profit Growth (YoY)
-8.48%
as of June 30, 2024
Industry median 23.11% (213 companies)
Revenue Growth (YoY)
-96.79%
as of March 31, 2016
Industry median 17.49% (205 companies)
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
-36.34
as of June 30, 2024
Industry median 8.97 (221 companies)
Net Margin
-14892.31%
as of Dec. 31, 2017
Industry median 7.49% (212 companies)
Operating Margin (EBIT)
-5663.33%
as of Dec. 31, 2017
Industry median 11.88% (214 companies)
Operating Margin (TTM)
-23.95%
as of June 30, 2024
Industry median 9.75% (219 companies)
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

0 of 2 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.9%
Low 3.6900 · High 3.7000
1W return
-8.9%
Low 3.6900 · High 4.0000
1M return
-32.9%
Low 3.6900 · High 5.3900
52W return
-12.6%
Low 3.6900 · High 6.9500
Lifetime High ₹60.3000 (Aug. 18, 2015)
Lifetime Low ₹1.2500 (Nov. 19, 2019)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
3.8
10D
4.0
20D
4.3
50D
4.6
100D
4.5
200D
4.2

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

3.69
Pivot
First resistance3.70
Second resistance3.70
Third resistance3.71
First support3.69
Second support3.68
Third support3.68
Day RSI25.1
Day MFI0.0
Day MACD-0.33
Day MACD signal-0.25

Beta

1M0.02
3M1.11
1Y1.11
3Y0.47

Price change analysis

↓ -32.9%
Over 1 Month
LowHigh
3.695.39
↓ -12.6%
Over 3 Months
LowHigh
3.696.95
↓ -12.6%
Over 6 Months
LowHigh
3.696.95
↓ -12.6%
Over 1 Year
LowHigh
3.696.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2024)
₹0 Cr
Net profit (June 30, 2024)
₹-1 Cr
Basic EPS (June 30, 2024)
₹-0.5600

Ranks #211 of 221 in Chemicals & Petrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter44.95%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 44.95% in Jun 2026 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
3 Aug 2026 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 137,380 7.8900 BSE
3 Aug 2026 RONAK ANILKUMAR Bulk Buy 138,871 7.6700 BSE
17 Jul 2026 DIPAKKUMAR BABALBHAI PATEL Bulk Buy 196,667 9.5300 BSE
16 Jul 2026 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 130,000 9.8200 BSE
14 Jul 2026 DEEPIKA JINDAL Bulk Buy 200,000 9.4000 BSE
16 Jun 2026 SUSHMA SANJAY PUNAMIYA Bulk Sell 122,295 6.5800 BSE
16 Jun 2026 DARSHANA MEHUL SHAH Bulk Sell 145,500 6.5800 BSE
8 Jun 2026 MEHUL PRAVIN CHANDRA SHAH Bulk Sell 162,880 5.2300 BSE
10 Dec 2018 JINESH ASHWIN MATALIA Bulk Sell 167,467 5.7000 BSE
10 Dec 2018 SIDDHARTH CHIMANLAL SHAH . Bulk Buy 175,000 5.7700 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Avon Lifesciences Limited to KOBO BIOTECH LIMITED
—NAME_CHANGEName changed from Avon Organics Ltd. to Avon Lifesciences Limited

All corporate actions →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Thin net profit margin (-14892.3%)
  • Declining revenue YoY (-96.8%)
  • Declining profit YoY (-8.5%)

Opportunities

  • RSI in oversold territory (25.1) -- a technical rebound zone

Threats

  • Weak interest coverage (-36.3x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about KOBO BIOTECH LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.